"Ketofol" a novel balanced intravenous anesthesia for multiple sclerosis patients posted for MRI
- PMID: 36778822
- PMCID: PMC9912905
- DOI: 10.4103/joacp.JOACP_15_21
"Ketofol" a novel balanced intravenous anesthesia for multiple sclerosis patients posted for MRI
Conflict of interest statement
There are no conflicts of interest.
References
-
- Dorotta IR, Schubert A. Multiple sclerosis and anesthetic implications. Curr Opin Anaesthesiol. 2002;15:365–70. - PubMed
-
- Sakai T, Ichiyama T, Whitten CW, Giesecke AH, Lipton JM. Ketamine suppresses endotoxin-induced NF-kappaB expression. Can J Anaesth. 2000;47:1019–24. - PubMed
-
- Sakai T, Tomiyasu S, Ono T, Yamada H, Sumikawa K. Multiple sclerosis with severe pain and allodynia alleviated by oral ketamine. Clin J Pain. 2004;20:375–6. - PubMed
-
- Andolfatto G, Abu-Laban RB, Zed PJ, Staniforth SM, Stackhouse S, Moadebi S, et al. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: A randomized double-blind trial. Ann Emerg Med. 2012;59:504–12. - PubMed
LinkOut - more resources
Full Text Sources